Product Images Cyclobenzaprine Hydrochloride

This is a table presenting the incidence of certain side effects associated with Cyclobenzaprine HCI tablets in two different doses (5mg and 10mg) compared to a placebo. The reported side effects are drowsiness, dry mouth, fatigue, and headache, along with the percentage of patients experiencing each side effect for each treatment group.*

Clinical studies have been conducted to evaluate the effects of Cyclobenzaprine HClI tablets with a dosage of 10mg. The studies found that 39% of patients reported drowsiness, 2% reported experiencing dry mouth, and 1% experienced dizziness. A surveillance program was also conducted and found that 16% of patients experienced drowsiness, 7% reported dry mouth, and 3% experienced dizziness while on Cyclobenzaprine HCI tablets with a 10mg dosage.*

This is a description of a medication called Cyclobenzaprine, which is sold as 10mg tablets. The LOT is stated as 11805915, and the Rx is noted as "Rx Only". The usual adult dosage is not provided, but it is advised to consult the information accompanying the product. The expiration date is marked as 04/03/19, and tablets should be stored at a temperature between 20°C and 25°C. The manufacturer is CIPL, and the medication is packaged by Contract Pharmacy Services in Pennsylvania, with CPSNDC: 67046-148-30.*